Phase I/II clinical trial of hypofractionated image-guided proton therapy for prostate cancer
- Conditions
- localized prostate cancer
- Registration Number
- JPRN-UMIN000038279
- Lead Sponsor
- agoya City University West Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 300
Not provided
1)pathological specimen is not available to confirm the diagnosis 2)previous radiotherapy around the lesion 3)surgery for prostate cancer is performed prior to registration 4)active and uncontrolled infection 5)two or more anticoagulants and antiplatelets 6)bowel disease such as ulcerative colitis or postoperative rectal cancer 7)patients who cannot or refuse gold markers and Space OAR 8)serious complication 9)cases in which the doctor is judged inappropriate for medical or other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The ratio of grade 2 or more acute genitourinary toxicity
- Secondary Outcome Measures
Name Time Method 5-year OS, bRFS, cRFS, bRF, cRF, Grade 2 or more late toxicity, QOL change